Literature DB >> 10556925

Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.

G C Wellman1, R Barrett-Jolley, H Köppel, D Everitt, J M Quayle.   

Abstract

1 The aim of this study was to investigate the selectivity of the ATP-sensitive potassium (K(ATP)) channel inhibitor U-37883A (4-morpholinecarboximidine-N-1-adamantyl-N'-1-cyclohexyl). Membrane currents through K(ATP) channels were recorded in single muscle cells enzymatically isolated from rat mesenteric artery, cardiac ventricle and skeletal muscle (flexor digitorum brevis). K(ATP) currents were induced either by cell dialysis with 0.1 mM ATP and 0.1 mM ADP, or by application of synthetic potassium channel openers (levcromakalim or pinacidil). 2 U-37883A inhibited K(ATP) currents in smooth muscle cells from rat mesenteric artery. Half inhibition of 10 microM levcromakalim-induced currents occurred at a concentration of 3.5 microM. 3 Relaxations of rat mesenteric vessels caused by levcromakalim were reversed by U-37883A. 1 microM levcromakalim-induced relaxations were inhibited at a similar concentration of U-37883A (half inhibition, 1.1 microM) to levcromakalim-induced KATP currents. 4 K(ATP) currents activated by 100 microM pinacidil were also studied in single myocytes from rat mesenteric artery, skeletal muscle and cardiac ventricle. 10 microM U-37883A substantially inhibited K(ATP) currents in vascular cells, but had little effect in skeletal or cardiac myocytes. Higher concentrations of U-37883A (100 microM) caused a modest decrease in K(ATP) currents in skeletal and cardiac muscle. The sulphonylurea K(ATP) channel antagonist glibenclamide (10 microM) abolished currents in all muscle types. 5 The effect of U-37883A on vascular inward rectifier (KIR) and voltage-dependent potassium (KV) currents was also examined. While 10 microM U-37883A had little effect on these currents, some inhibition was apparent at higher concentrations (100 microM) of the compound. 6 We conclude that U-37883A inhibits K(ATP) channels in arterial smooth muscle more effectively than in cardiac and skeletal muscle. Furthermore, this compound is selective for K(ATP) channels over KV and KIR channels in smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556925      PMCID: PMC1571709          DOI: 10.1038/sj.bjp.0702868

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.

Authors:  C E Ohrnberger; S A Khan; K D Meisheri
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

2.  Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.

Authors:  E Guillemare; E Honore; J De Weille; M Fosset; M Lazdunski; K Meisheri
Journal:  Mol Pharmacol       Date:  1994-07       Impact factor: 4.436

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.

Authors:  S N Russell; S V Smirnov; P I Aaronson
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 5.  Correlating structure and function in ATP-sensitive K+ channels.

Authors:  F M Ashcroft; F M Gribble
Journal:  Trends Neurosci       Date:  1998-07       Impact factor: 13.837

6.  4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.

Authors:  K D Meisheri; S J Humphrey; S A Khan; L A Cipkus-Dubray; M P Smith; A W Jones
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

7.  Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.

Authors:  K Meisheri; M Fosset; S Humphrey; M Lazdunski
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

8.  The effect of intracellular anions on ATP-dependent potassium channels of rat skeletal muscle.

Authors:  H C McKillen; N W Davies; P R Stanfield; N B Standen
Journal:  J Physiol       Date:  1994-09-15       Impact factor: 5.182

9.  Characterization of potassium currents modulated by BRL 38227 in rat portal vein.

Authors:  T Noack; P Deitmer; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

10.  Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein.

Authors:  D J Beech; H Zhang; K Nakao; T B Bolton
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more
  9 in total

1.  Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.

Authors:  H Kovalev; J M Quayle; T Kamishima; D Lodwick
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

2.  The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro.

Authors:  Alastair J O'Brien; Gita Thakur; James F Buckley; Mervyn Singer; Lucie H Clapp
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock.

Authors:  Solène Collin; Nacira Sennoun; Anne-Gaëlle Dron; Mathilde de la Bourdonnaye; Chantal Montemont; Pierre Asfar; Patrick Lacolley; Ferhat Meziani; Bruno Levy
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440

4.  Pituitary adenylate cyclase activating polypeptide (PACAP) dilates cerebellar arteries through activation of large-conductance Ca(2+)-activated (BK) and ATP-sensitive (K ATP) K (+) channels.

Authors:  Masayo Koide; Arsalan U Syed; Karen M Braas; Victor May; George C Wellman
Journal:  J Mol Neurosci       Date:  2014-04-18       Impact factor: 3.444

5.  Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.

Authors:  Yi Cui; Andrew Tinker; Lucie H Clapp
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor.

Authors:  Murali Gopalakrishnan; Thomas R Miller; Steven A Buckner; Ivan Milicic; Eduardo J Molinari; Kristi L Whiteaker; Rachel Davis-Taber; Victoria E Scott; Christopher Cassidy; James P Sullivan; William A Carroll
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

7.  ATP-sensitive potassium channels induced in liver cells after transfection with insulin cDNA and the GLUT 2 transporter regulate glucose-stimulated insulin secretion.

Authors:  Guo Jun Liu; Ann M Simpson; M Anne Swan; Chang Tao; Bernard E Tuch; Russell M Crawford; Aleksandar Jovanovic; Donald K Martin
Journal:  FASEB J       Date:  2003-07-18       Impact factor: 5.191

8.  Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the KATP channel.

Authors:  Maria S Remedi; Jonathan B Friedman; Colin G Nichols
Journal:  J Gen Physiol       Date:  2016-12-12       Impact factor: 4.086

Review 9.  Ion Channels in the Paraventricular Hypothalamic Nucleus (PVN); Emerging Diversity and Functional Roles.

Authors:  Claire H Feetham; Fiona O'Brien; Richard Barrett-Jolley
Journal:  Front Physiol       Date:  2018-07-06       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.